The company is facing generic competition just like many of the other major pharmaceutical companies and also in the news they are attempting to purchase another biotech company, Genzyme.
Sanofi Proposal to Acquire Genzyme Rejected–Looking for Other Alternatives
Genzyme was probably not heard of by many until they had a real live virus in their systems and was the corner of corner of concern from the FDA as well with shutting down the plant twice while the vats were cleaned. Genzyme is the sole manufacturer of a couple drugs used to treat rare genetic diseases.
Virus hits Genzyme plant – Virus Infected Hamster Ovary Cells
We might guess that sales and marketing could be in the group here since pharma reps are steadily becoming a much smaller group anymore. Plavix is one of the company’s best selling drugs, a name you may recognize. BD
French pharmaceutical giant Sanofi-Aventis has announced it will shed 1,700 jobs from its US workforce.
The move is part of a restructuring process that will allow the company to focus on drugs for diabetes, cancer and heart problems, it said.
The cuts represent 13% of the firm's total workforce of 13,000 in the US.
Like many major pharmaceuticals companies, Sanofi is facing increased competition from generic drug companies.
BBC News - Sanofi-Aventis to cut 1,700 jobs in the US
Hat Tip: Pharmagossip
0 comments :
Post a Comment